Aadi Bioscience Stock Price

0.23 (1.22%)
Upgrade to Real-Time
Regular Market
Volume 4,507
Bid Price 18.93
Ask Price 19.17
News -
Day High 19.49


52 Week Range


Day Low 18.92
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aadi Bioscience Inc AADI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.23 1.22% 19.09 10:19:37
Open Price Low Price High Price Close Price Prev Close
19.25 18.92 19.49 18.86
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
119 4,507 $ 19.09 $ 86,054 - 17.15 - 32.99
Last Trade Time Type Quantity Stock Price Currency
10:19:37 33 $ 19.055 USD


Draw Mode:

Aadi Bioscience Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 398.87M 20.89M 35.59M $ - $ - -19.37 -1.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 185.00k 0.10%

more financials information »

Aadi Bioscience News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AADI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week19.9421.4217.1518.97198,293-0.85-4.26%
1 Month23.7825.35517.1521.41148,709-4.69-19.72%
3 Months28.4632.5017.1523.55219,837-9.37-32.92%
6 Months30.0032.9917.1524.37149,086-10.91-36.37%
1 Year30.0032.9917.1524.37149,086-10.91-36.37%
3 Years30.0032.9917.1524.37149,086-10.91-36.37%
5 Years30.0032.9917.1524.37149,086-10.91-36.37%

Aadi Bioscience Description

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site.
Your Recent History
Aadi Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220127 15:34:57